Connor, Clark & Lunn Investment Management (CC&L)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.58M Buy
2025
Q1
$2.19M Buy
2024
Q4
$1.51M Buy
2024
Q3
$520K Buy
2024
Q2
$328K Buy
2024
Q1
Sell
2023
Q4
$3.47M Sell
2023
Q3
$4.82M Sell
2023
Q2
$5.33M Buy
2023
Q1
$5.18M Buy
2022
Q4
$3.75M Buy
2019
Q4
Sell
2019
Q3
$508K Buy
2016
Q1
Sell
2015
Q4
$468K Buy
2015
Q3
$408K Buy